TachoSil
TachoSil is a pharmaceutical drug with 19 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
15 of 15 finished
0.0%
0 ended early
2
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
GATT-Patch Versus TachoSil in Liver Surgery
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery
Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
Assessment of Long-term Effects of Tachosil
Clinical Trials (19)
GATT-Patch Versus TachoSil in Liver Surgery
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery
Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
Assessment of Long-term Effects of Tachosil
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation
Observational Pilot Study With TachoSil as a Ventricular Sealant
Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia
Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection
RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study
A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery
The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
Use of Tachosil® for Lymph Sealing During Surgery
TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery
Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection
TASALL - TachoSil® Against Liquor Leak
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19